iifl-logo-icon 1
iifl-logo-icon 1Budget 2024
iifl-logo-icon 1
Home

Ipca Laboratories Ltd Board Meeting

₹1,241.2
(2.26%)
Jul 23, 2024|03:32:38 PM

Ipca Labs. CORPORATE ACTIONS

24/07/2023calendar-icon
23/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting29 May 20247 May 2024
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Standalone and Consolidated Audited Financial Results for the 4th quarter and financial year ended 31st March 2024 and recommendation of final dividend for FY 23-24 Board recommends final dividend Outcome of Board Meeting held on 29th May, 2024 (As Per BSE Announcement dated on 29.05.2024)
Board Meeting14 Feb 202422 Jan 2024
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the 3rd quarter and nine months ended 31.12.2023 Outcome of Board Meeting held on 14.02.2024 Standalone and Consolidated Q3FY24 Results and Press Release (As Per BSE Announcement Dated on 14/02/2024)
Board Meeting10 Nov 202325 Oct 2023
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve Standalone and Consolidated Unaudited Results for Q2 H1FY24 and Interim Dividend Record Date for Interim Dividend 2023-24 Board approves Dividend Board has approved Interim dividend of Rs. 2/- per equity share (200%) Standalone and Consolidated Results for 2nd quarter and half year ended 30th September, 2023 (As Per BSE Announcement Dated on 10.11.2023)
Board Meeting10 Aug 202321 Jul 2023
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for 1st quarter ended 30th June 2023. Standalone and Consolidated Q1FY24 Results & Press Release (As Per BSE Announcement dated on 10.08.2023)

Ipca Labs.: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

QUICKLINKS FOR Ipca Laboratories Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.